Banwell CM et al. |
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. |
2004 |
J. Steroid Biochem. Mol. Biol. |
pmid:15225779
|
Fang JY et al. |
Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. |
2004 |
Cell Res. |
pmid:15225415
|
Sumer H et al. |
Effects of scaffold/matrix alteration on centromeric function and gene expression. |
2004 |
J. Biol. Chem. |
pmid:15220334
|
Jia S et al. |
RNAi-independent heterochromatin nucleation by the stress-activated ATF/CREB family proteins. |
2004 |
Science |
pmid:15218150
|
Ishihara K et al. |
Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. |
2004 |
Br. J. Pharmacol. |
pmid:15210580
|
Korzus E et al. |
CBP histone acetyltransferase activity is a critical component of memory consolidation. |
2004 |
Neuron |
pmid:15207240
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|
Moldenhauer A et al. |
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. |
2004 |
J. Leukoc. Biol. |
pmid:15197237
|
Lu H et al. |
Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. |
2004 |
J. Virol. |
pmid:15194748
|
Ng Y et al. |
Expression of the human myotonic dystrophy kinase-related Cdc42-binding kinase gamma is regulated by promoter DNA methylation and Sp1 binding. |
2004 |
J. Biol. Chem. |
pmid:15194684
|
Sakamoto S et al. |
Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. |
2004 |
J. Biol. Chem. |
pmid:15194680
|
Brieger A et al. |
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. |
2004 |
Biochem. Pharmacol. |
pmid:15183120
|
Ishiguro K and Sartorelli AC |
Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A. |
2004 |
Eur. J. Biochem. |
pmid:15182353
|
Vanhaecke T et al. |
Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. |
2004 |
Curr. Med. Chem. |
pmid:15180568
|
Ahn MR et al. |
Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells. |
2004 |
Arch. Pharm. Res. |
pmid:15180307
|
Flørenes VA et al. |
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. |
2004 |
Melanoma Res. |
pmid:15179185
|
Lee YJ et al. |
Mechanism of transcriptional repression by TEL/RUNX1 fusion protein. |
2004 |
Mol. Cells |
pmid:15179033
|
Zhang X et al. |
Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. |
2004 |
Mol. Cell. Biol. |
pmid:15169878
|
Ronai D et al. |
The epigenetic stability of the locus control region-deficient IgH locus in mouse hybridoma cells is a clonally varying, heritable feature. |
2004 |
Genetics |
pmid:15166165
|
Glenn MP et al. |
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine. |
2004 |
J. Med. Chem. |
pmid:15163181
|
Zhang Y et al. |
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. |
2004 |
Radiat. Res. |
pmid:15161353
|
Wang LG et al. |
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. |
2004 |
Oncogene |
pmid:15156193
|
Zoumpoulidou G et al. |
Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y). |
2004 |
Mol. Endocrinol. |
pmid:15155784
|
Kato N et al. |
Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. |
2004 |
Cell Death Differ. |
pmid:15153943
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Kurtev V et al. |
Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. |
2004 |
J. Biol. Chem. |
pmid:15140878
|
Jin YH et al. |
Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. |
2004 |
J. Biol. Chem. |
pmid:15138260
|
Winn RA and Heasley LE |
Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth. |
2004 |
Chest |
pmid:15136458
|
Ishii S et al. |
Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. |
2004 |
Mol. Endocrinol. |
pmid:15131262
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Iezzi S et al. |
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. |
2004 |
Dev. Cell |
pmid:15130492
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Fu M et al. |
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
2004 |
J. Biol. Chem. |
pmid:15123687
|
Klampfer L et al. |
Requirement of histone deacetylase activity for signaling by STAT1. |
2004 |
J. Biol. Chem. |
pmid:15123634
|
Mizukami T et al. |
Effects of trichostatin a, a histone deacetylase inhibitor, on mouse gonadal development in vitro. |
2004 |
J. Reprod. Dev. |
pmid:15118250
|
Arapshian A et al. |
Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. |
2004 |
Mol. Cancer |
pmid:15113415
|
Marson CM et al. |
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109636
|
Nishino N et al. |
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109626
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
Lasa A et al. |
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. |
2004 |
Leukemia |
pmid:15103390
|
Jansen MS et al. |
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15103026
|
Tani M et al. |
Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. |
2004 |
Genes Chromosomes Cancer |
pmid:15101048
|
Munro J et al. |
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. |
2004 |
Exp. Cell Res. |
pmid:15093749
|
Chang HC et al. |
Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. |
2004 |
Cell. Signal. |
pmid:15093608
|
Milutinovic S et al. |
DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. |
2004 |
J. Biol. Chem. |
pmid:15087453
|
Amor DJ et al. |
Human centromere repositioning "in progress". |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15084747
|
Ahmed S et al. |
A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast. |
2004 |
Mol. Cell. Biol. |
pmid:15082762
|
Romanski A et al. |
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. |
2004 |
Haematologica |
pmid:15075075
|
Margueron R et al. |
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. |
2004 |
J. Mol. Endocrinol. |
pmid:15072561
|